265 related articles for article (PubMed ID: 23966771)
1. Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases.
Allarakhia M
Drug Des Devel Ther; 2013; 7():753-66. PubMed ID: 23966771
[TBL] [Abstract][Full Text] [Related]
2. Understanding and creating value from open source drug discovery for neglected tropical diseases.
Allarakhia M; Ajuwon L
Expert Opin Drug Discov; 2012 Aug; 7(8):643-57. PubMed ID: 22657529
[TBL] [Abstract][Full Text] [Related]
3. Repurposing strategies for tropical disease drug discovery.
Klug DM; Gelb MH; Pollastri MP
Bioorg Med Chem Lett; 2016 Jun; 26(11):2569-76. PubMed ID: 27080183
[TBL] [Abstract][Full Text] [Related]
4. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
Jain P; Jain SK; Jain M
Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
[TBL] [Abstract][Full Text] [Related]
5. Actives from MMV Open Access Boxes? A suggested way forward.
Samby K; Willis PA; Burrows JN; Laleu B; Webborn PJH
PLoS Pathog; 2021 Apr; 17(4):e1009384. PubMed ID: 33886696
[TBL] [Abstract][Full Text] [Related]
6. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.
Dichiara M; Marrazzo A; Prezzavento O; Collina S; Rescifina A; Amata E
ChemMedChem; 2017 Aug; 12(16):1235-1253. PubMed ID: 28590590
[TBL] [Abstract][Full Text] [Related]
8. Progress Report on Neglected Tropical Disease Drug Donation Programs.
Cohen JP; Silva L; Cohen A; Awatin J; Sturgeon R
Clin Ther; 2016 May; 38(5):1193-204. PubMed ID: 27041410
[TBL] [Abstract][Full Text] [Related]
9. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
Ioset JR; Chang S
Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
[TBL] [Abstract][Full Text] [Related]
10. Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases.
Bellera CL; Sbaraglini ML; Talevi A
Curr Top Med Chem; 2018; 18(5):369-381. PubMed ID: 29741140
[TBL] [Abstract][Full Text] [Related]
11. The importance of patent sharing in neglected disease drug discovery.
Edlin C
Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
[No Abstract] [Full Text] [Related]
12. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
[TBL] [Abstract][Full Text] [Related]
13. Teach-Discover-Treat (TDT): collaborative computational drug discovery for neglected diseases.
Jansen JM; Cornell W; Tseng YJ; Amaro RE
J Mol Graph Model; 2012 Sep; 38():360-2. PubMed ID: 23085175
[TBL] [Abstract][Full Text] [Related]
14. Yeast as a potential vehicle for neglected tropical disease drug discovery.
Denny PW; Steel PG
J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
[TBL] [Abstract][Full Text] [Related]
15. Fostering innovative product development for neglected tropical diseases through partnerships.
Starr A; Graef KM; Dent J
Pharm Pat Anal; 2016 Sep; 5(6):391-400. PubMed ID: 27813447
[TBL] [Abstract][Full Text] [Related]
16. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
17. Innovative partnerships for drug discovery against neglected diseases.
Jakobsen PH; Wang MW; Nwaka S
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1221. PubMed ID: 21980540
[No Abstract] [Full Text] [Related]
18. Onchocerciasis drug development: from preclinical models to humans.
Ngwewondo A; Scandale I; Specht S
Parasitol Res; 2021 Dec; 120(12):3939-3964. PubMed ID: 34642800
[TBL] [Abstract][Full Text] [Related]
19. First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium.
Musselwhite LW; Maciag K; Lankowski A; Gretes MC; Wellems TE; Tavera G; Goulding RE; Guillen E
Am J Trop Med Hyg; 2012 Jan; 86(1):65-74. PubMed ID: 22232453
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective.
Ferreira LG; Andricopulo AD
Drug Discov Today; 2016 Oct; 21(10):1699-1710. PubMed ID: 27365271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
